Spangler Patrick D's Form 4 filing
OptimizeRx Corp (OPRX) · filed Sep 11, 2025
- Accession no.
- 0001296525-25-000002
- Filed
- Sep 11, 2025
- Trade date
- Aug 28, 2025
- Filing delay
- 14 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $194.5K. It was filed 14 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spangler Patrick DCIK 0001296525 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | Common Stock | SSaleDisposed | −11,120 | $17.49 | −$194,488.8 | 44,215 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.